Phase
Condition
Gout (Hyperuricemia)
Treatment
araboxylan
placebo control
inulin and araboxylan
Clinical Study ID
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Local residents aged between 18-80 years old;
Stable weight (<5% weight change over the past 3 months);
Fsating uric acid > 420 umol/L for male and > 360 umol/L for female on twodifferent days;
Not taking uric acid lowering drugs or have stopped taking uric acid loweringdrugs for over 4 weeks at the time of recruitment;
Absence of any diet or medication that might interfere with uric acidmetabolims or gut microbiota, especially antibiotics, prebiotics or probioticsat the least 4 weeks before recruitment
Exclusion
Exclusion Criteria:
Acute illness or evidence of any acute or chronic inflammatroy of infectivediseases;
Participation in regular diet program more than 2 times per week in the lastest 3 months prior to recruitment;
Mental illness rendering them unable to understand the nature, scope, andpossible consequences of the study;
Women of childbearing age who are pregant, breast-feeding or preparing forpregnancy; patients who had surgey within the past 6 months or planned surgeryduring the trial period.
Study Design
Study Description
Connect with a study center
Department of Nutrition and Food Hygiene
Guangzhou, Guangdong 510080
ChinaActive - Recruiting
Sun Yat-Sen University
Guangzhou, Guangdong 510080
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.